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Background: Platelet-derived growth factor (PDGF)
promotes mitogenesis in fibroblast cell lines but stimulates
neurite outgrowth in PC12 cells that ectopically express
the PDGF receptor. To determine which substrates
must associate with this receptor protein-tyrosine kinase
in order to promote neurite outgrowth, we introduced
into PC12 pheochromocytoma cells three mutant forms
of the PDGF receptor that no longer associate with
specific substrate proteins. We then assayed the ability of
these receptor mutants to affect neurite extension.
Results: Receptors lacking the kinase-insert domain did
not associate with either phosphatidylinositol 3-kinase (PI
3-kinase) or Ras GTPase-activating protein (Ras-GAP)
in PC12 cells. A carboxy-terminal truncation of the 
PDGF receptor eliminated the association of phospho-
lipase C-yl (PLC-yl) with the receptor and prevented
phosphorylation of PLC-yIl in PC12 cells. Finally, 3
PDGF receptors that have tyrosine-to-phenylalanine
point mutations at positions 708, 719, 977 and 989 did
not associate with either PI 3-kinase or PLC-'yl. All three
mutant forms of the 3 PDGF receptor promoted PDGF-
dependent neurite outgrowth in PC12 cells and elicited
activation of mitogen-activated protein (MAP) kinases.
Conclusions: PC12 cells expressing the 3 PDGF recep-
tor extend neurites in response to PDGF in the absence of
signalling through PI 3-kinase, RasGAP, and PLC-yl.
This contrasts with the requirements for mitogenesis for
epithelial and fibroblast cell lines, in which the association
of PI 3-kinase with the PDGF receptor is essential. This
receptor protein-tyrosine kinase therefore phosphorylates
and activates a similar set of intracellular signalling mol-
ecules in the context of both mitogenesis and differentia-
tion, but the importance of particular pathways for each
phenotypic response is distinct.
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Background
Many peptide growth factors exert their effects on a tar-
get cell by binding to and activating receptors that have
intrinsic protein-tyrosine kinase activity [1]. Some recep-
tor protein-tyrosine kinases promote proliferation and
some support differentiation and survival, depending
both on the type of receptor and the cell type that
expresses it. Despite this diversity of cellular responses,
most receptor tyrosine kinases have been shown to inter-
act with and phosphorylate similar cytoplasmic signalling
molecules and to activate similar downstream signalling
pathways in response to binding ligand [2]. Several cyto-
plasmic signalling molecules have been shown to be criti-
cal mediators of the proliferative response following
receptor tyrosine kinase activation, but much less is
understood about how differentiation is regulated.
The PC12 cell line, derived from a rat pheochromo-
cytoma, has served as a model system for investigating
how certain growth factors regulate neuronal differentia-
tion. Within several days of treatment with nerve growth
factor (NGF) or fibroblast growth factor (FGF), the cells
differentiate and acquire features characteristic of sympa-
thetic neurons, such as the ability to extend neurites
[3,4]. NGF binds to Trk, a member of the receptor tyro-
sine kinase family, and Trk is likely to mediate most of
the biological responses to NGF [5-7]. Upon ligand
binding, Trk associates with a number of intracellular sig-
nalling molecules, including phospholipase C-yl (PLC-
yl), phosphatidyl inositol 3-kinase (PI 3-kinase), the
Erkl kinase, and the adaptor protein Shc [8-10]. It has
recently been shown that Trk's ability to regulate neurite
outgrowth depends upon association of both Shc and
PLC-yl with the receptor [11,12].
Expression in PC12 cells of the 3 subunit of the receptor
for platelet-derived growth factor (PDGF) renders the
cells able to respond to PDGF by differentiating and
extending neurites [13]. A number of intracellular sig-
nalling proteins have been shown to interact with the
PDGF receptor, and by deleting or mutating the
phosphotyrosine residues on the PDGF receptor that
mediate association with many of these signalling mol-
ecules, it has been possible to assess the significance of
specific interactions for the ability of the receptor to pro-
mote cell proliferation in fibroblast and epithelial cell
lines. We therefore reasoned that this receptor could pro-
vide a means for further exploring the signalling pathways
that are required downstream of receptor tyrosine kinase
activation in order to elicit PC 12 cell differentiation.
The kinase domain of the PDGF receptor is interrupted
by a stretch of approximately 100 amino acids, known as
the kinase insert domain. Within this region, two
phosphotyrosine residues at positions 708 and 719 mediate
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the binding of PI 3-kinase [14-18], and phosphotyrosine
residue 719 also mediates interactions with the adaptor-
like protein, Nck [19]. Phosphotyrosine residue 739 is
required for association of the receptor with the Ras
GTPase-activating protein (Ras-GAP) [16-18]. De-
letion of 82 amino acids from the kinase insert region
renders the PDGF receptor incapable of promoting a
mitogenic response in most fibroblast and epithelial cell
lines, even though kinase activity is retained [20]. Point
mutations suggest that the integrity of the PI 3-
kinase/Nck binding sites is most critical for PDGF-
mediated mitogenicity [16,17].
Two phosphotyrosines, at positions 977 and 989, in the
carboxy-terminal tail of the PDGF receptor mediate
association with the protein tyrosine phosphatase Syp and
PLC-yl, respectively [21-24]. Mutation of tyrosine 989
or both tyrosines 977 and 989 of the receptor results in it
eliciting a normal or slightly reduced mitogenic response
to PDGF stimulation in most fibroblast and epithelial cell
lines [22-24]. Two phosphotyrosines in the juxtamem-
brane region of the receptor, at positions 557 and 559,
seem to mediate association with three members of the
Src family of non-receptor tyrosine kinases, Src, Yes and
Fyn [25]. When both tyrosines corresponding to residues
557 and 559 in the human 3 PDGF receptor are mutated
to phenylalanine, however, the kinase activity of the
receptor is compromised, hindering assessment of the
contribution of this association to mitogenesis. Injection
of NIH 3T3 fibroblast cells with either dominant-nega-
tive mutant forms of Src and Fyn, or antibodies specific
for Src, Yes and Fyn, inhibits PDGF-stimulated DNA
synthesis, suggesting that these tyrosine kinases play
important roles in mediating the mitogenic signal follow-
ing binding of PDGF to its receptor [26].
Although receptor protein-tyrosine kinases interact with
similar cytoplasmic signalling molecules when regulating
both cell proliferation and differentiation, it is not yet
clear whether the requirements for both processes are the
same or distinct. We have therefore expressed several
mutant forms of the PDGF receptor in PC12 cells, in an
attempt to determine whether the association of certain
cytoplasmic signalling molecules with a receptor tyrosine
kinase is required to promote a differentiation response,
such as neurite outgrowth. We show that regulation of
neurite extension in PC12 cells by the PDGF receptor
does not depend upon the receptor's association with PI
3-kinase, Ras-GAP or PLC-yl. These results suggests
that the PDGF receptor uses distinct signalling pathways
to promote two different phenotypic responses, namely
mitogenesis and differentiation. The role of Syp in regu-
lating neurite outgrowth is still in question, as elimination
of the reported binding site for Syp did not completely
disrupt its association with the PDGF receptor.
Results
Expression of PDGF receptor mutants in PC12 cells
To assess the importance of specific signalling molecules
in a differentiation response, we expressed in PC12 cells
Fig. 1. Proteins that associate with wild-type and mutant forms of the PDGF 3 receptor. (a) Wild-type PDGF 3 receptor (WT) associates
with Src family tyrosine kinases, PI 3-kinase (PI 3K), Nck, Ras-GAP, phospholipase C-yl (PLC-yl), and the tyrosine phosphatase Syp
119,21,57,74-82]. (b) The AKI form of the PDGF 3 receptor has a deletion of residues 684-765 within the kinase insert region [20].
The AKI form lacks the binding sites for PI 3-kinase, Ras-GAP and Nck [16-19,801. (c) The Trunc form of the PDGF 3 receptor has a
truncation of the carboxyl terminus, caused by mutation of tyrosine 977 to a stop codon. The Trunc form lacks the reported binding
sites for PLC-'yl and Syp [21-24]. (d) The 4F PDGF 13 receptor has tyrosine-to-phenylalanine mutations at positions 708, 719, 977 and
989. These mutations alter the reported binding sites for PI 3-kinase, PLC-y1, Syp and Nck [1-19,21-24,80].
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Fig. 2. Ectopic expression of PDGF receptor in PC12 cells. 50 RJg
of total protein were resolved on a 6 % SDS polyacrylamide gel.
Following transfer to nitrocellulose, the blot was probed with an
antibody that recognizes the mouse PDGF Pi receptor (Ab 65). (a)
Cell lysates were prepared from untransfected PC12 cells (lane
1), PC12 cells transfected with cDNAs encoding either WT (lane
2), AKI (lane 3) or Trunc (lane 4) forms of the mouse PDGF 3
receptor, or from Balb/c 3T3 cells (lane 5). (b) Cell lysates were
prepared from PC12 cells transfected with a cDNA encoding the
4F form of the PDGF receptor (lane 1). Lysate from Balb/c 3T3
cells (lane 2) is included as a reference.
either the full-length mouse PDGF receptor 3 subunit
(WT in Fig. la), or one of three mutant versions of the
receptor described in Figure 1. PC12 cells do not nor-
mally express the PDGF receptor (Fig. 2a, lane 1). PC12
cell clones expressing either the WT, AKI, Trunc or 4F
forms of the mouse PDGF receptor 3 subunit were
generated and their expression assessed by western
immunoblotting (Fig. 2a, lanes 2-4, Fig. 2b, lane 2, one
example of each shown). The electrophoretic mobility of
the full-length PDGF receptor on SDS polyacrylamide
gels was slower in lysates of PC12 cells (Fig. 2a, lane 2)
than in lysates of mouse Balb/c 3T3 cells, in which the
receptor is endogenously expressed (Fig. 2a, lane 5). This
may be attributed to glycosylation differences between
the two cell types, as the immature receptors (lower band
in Fig. 2a, lanes 2 and 5) in each cell type were more
similar to each other in electrophoretic mobility. The
AKI and Trunc forms of the receptor both migrated on
SDS gels more quickly than the full length PDGF recep-
tor (WT), as expected. Figure 2b shows expression of the
4F form of the PDGF receptor in PC12 cells (lane 2) rel-
ative to expression of the PDGF receptor in Balb/c 3T3
cells (lane 1). When normalized to the levels of expres-
sion in Balb/c 3T3 cells, the 4F form of the PDGF
receptor seems to be expressed at lower levels than the
other forms of the PDGF receptor.
To determine whether all four forms of the PDGF recep-
tor were catalytically active when expressed in PC12
cells, we assayed for PDGF-stimulated changes in pro-
tein-tyrosine phosphorylation by western immuno-
blotting using an antibody (4G10) that is specific for
phosphorylated tyrosine residues. Untransfected PC12
cells stimulated with NGF for 5 minutes showed typical
changes in total cellular phosphotyrosine (Fig. 3a, lanes
1-2), but showed no changes in total cellular phospho-
tyrosine when stimulated with PDGF (Fig. 3a, lane 3).
PC12 cells expressing all four versions of the PDGF
receptor responded to PDGF stimulation with an increase
Fig. 3. PDGF induces rapid changes
in protein-tyrosine phosphorylation in
PC12 cells expressing each form of the
PDGF receptor. Before lysis, cells were
either left unstimulated (-) or stimulated
with 50 ng ml-' NGF (N) or 40 ng ml-'
PDGF BB (P) for 5 minutes at 37 OC.
50 ,ug of each cell lysate was resolved
on a 7 % SDS polyacrylamide gel,
transferred to nitrocellulose and the blot
probed with 4G10, an anti-phospho-
tyrosine antibody.(a) Cell lysates were
prepared from untransfected PC12 cells
(lanes 1-3); PC12 cells expressing WT
(lanes 4-5), KI (lanes 6-7) or Trunc
(lanes 8-9) forms of the PDGF receptor;
and from Balb/c 3T3 cells (lanes
10-11). (b) Cell lysates were prepared
from PC12 cells expressing the 4F form
of the PDGF receptor (lanes 3-4).
Lysates from PC12 cells expressing WT
PDGF receptor (lanes 1-2) are included
for reference.
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Fig. 4. PDGF receptor association with
PI 3-kinase activity in PC12 cells is dis-
rupted by deletion of the receptor's
kinase insert region. Cells were either
left unstimulated (-) or stimulated with
40 ng ml-1 PDGF BB (+) for 5 minutes at
37 °C before lysis. The PDGF receptor
was immunoprecipitated and a PI 3-
kinase assay performed on the immuno-
precipitates. The products of the reac-
tion were resolved from bottom to top
on a silica gel plate by thin layer chro-
matography and the plate then exposed
to Xomat AR film (Kodak). (a) Lysates
were prepared from untransfected PC12
cells (lanes 1-2), PC12 cells expressing
WT (lanes 3-4) or AKI (lanes 5-6) forms
of the PDGF receptor, or Balb/c 3T3
cells (lanes 7-8). (b) Lysates were pre-
pared from PC12 cells expressing the 4F
PDGF receptor (lanes 1-2) or from
Balb/c 3T3 cells (lanes 3-4).
in the number of tyrosine phosphorylated proteins (Fig.
3a, lanes 4-9; Fig. 3b, lanes 3-4)
Following NGF stimulation, all PC12 cell clones showed
identical patterns of protein-tyrosine phosphorylation,
demonstrating that Trk activation was normal in all the
clones (data not shown). The pattern of tyrosine-phos-
phorylated proteins following PDGF stimulation of
receptor-expressing PC12 cells (Fig. 3a, lanes 5, 7, 9; Fig.
3b, lane 4) was comparable, but not identical, to that seen
with NGF stimulation (Fig. 3a, lane 2). In particular, a
tyrosine-phosphorylated protein migrating in the size
range of the autophosphorylated PDGF receptor
(approximately 180 kD) was quite prominent following
PDGF stimulation (Fig. 3a, lanes 5, 7, 9; Fig. 3b, lane 4).
In addition, there were some subtle differences in the
patterns of tyrosine-phosphorylated proteins following
PDGF stimulation of PC12 cells expressing the different
forms of the PDGF receptor. These differences may be
attributable to loss of binding sites for specific substrate
molecules on the mutated forms of the PDGF receptor.
Association of the PDGF receptor with PI 3-kinase and
Ras-GAP in PC12 cells
To confirm that the binding sites for PI 3-kinase on the
PDGF receptor had been lost by deleting the kinase
insert region or mutating specific tyrosine residues
within this region, we performed a lipid kinase assay on
PDGF receptor immunoprecipitates from the various
cell lines. PI 3-kinase activity was detected in PDGF
receptor immunoprecipitates from Balb/c 3T3 cells fol-
lowing PDGF stimulation (Fig. 4a, lanes 7-8; Fig. 4b,
lanes 3-4), but not from untransfected PC12 cells (Fig.
4a, lanes 1-2). PI 3-kinase activity co-precipitated in a
PDGF-dependent manner with the PDGF receptor from
lysates of PC12 cells expressing the full length WT
PDGF receptor (Fig. 4a, lanes 3-4), however, and this
co-precipitation was disrupted in PC12 cells expressing
either the AKI version of the receptor (Fig. 4a, lanes
5-6) or the 4F form of the receptor (Fig. 4b, lanes 1-2).
Similar results were obtained when the lipid kinase assay
was performed following immunoprecipitation with an
anti-phosphotyrosine antibody (data not shown).
To demonstrate that the 3 PDGF receptor also associated
with Ras-GAP in PC12 cells using sequences contained
within the kinase insert region, we immunoprecipitated
Ras-GAP from each of the cell lines and performed a
western blot using the 4G10 anti-phosphotyrosine anti-
body. Ras-GAP was not phosphorylated in response to
PDGF stimulation of untransfected PC12 cells (Fig. 5,
lanes 1-2). Following PDGF treatment of Balb/c 3T3
cells (Fig. 5, lanes 7-8), or PC12 cells expressing the
full length (WT) PDGF receptor (Fig. 5, lanes 3-4),
Fig. 5. Ras-GAP association with the PDGF receptor in PC12
cells is disrupted by deletion of the kinase insert region.
Untransfected PC12 cells (lanes 1-2), PC12 cells expressing WT
(lanes 3-4) or AKI (lanes 5, 6) PDGF receptor, or Balb/c 3T3
cells (lanes 7-8) were either left unstimulated (-) or stimulated
with 40 ng ml-1 PDGF BB (+) for 5 minutes at 37 C before lysis.
Ras-GAP was immunoprecipitated and the immunoprecipitated
proteins resolved on a 6 % SDS polyacrylamide gel, transferred
to nitrocellulose and probed with an anti-phosphotyrosine anti-
body (4G10).
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Fig. 6. PLC-'y1 association with the PDGF
receptor in PC12 cells is disrupted by
deletion of the receptor's carboxy-termi-
nal tail. PLC-yl was immunoprecipitated
from cell lysates and the immuno-
precipitated proteins resolved on a 6 %
SDS polyacrylamide gel, transferred to
nitrocellulose and probed with an anti-
phosphotyrosine antibody (4G10). (a)
Untransfected PC12 cells (lanes 1-2),
PC12 cells expressing WT (lanes 3-4) or
Trunc (lanes 5-6) PDGF receptor, or
Balb/c 3T3 cells (lanes 7-8) were either
left unstimulated (-) or stimulated with 40
ng ml 1 PDGF BB (+) for 5 minutes at
37 C before lysis. (b) PC12 cells express-
ing the 4F PDGF receptor (lanes 3-4)
were either left unstimulated (-) or stimu-
lated with 40 ng ml -' PDGF BB (+), and
then lysed. Lanes of lysates from unstimu-
lated or PDGF-stimulated PC12 cells
expressing the WT PDGF receptor (lanes
1-2) are included for reference.
Ras-GAP became phosphorylated on tyrosine and asso-
ciated with tyrosine-phosphorylated PDGF receptor. This
association was disrupted in PC12 cells expressing the
AKI version of the PDGF receptor (Fig. 5, lanes 5-6).
Association of the PDGF receptor with PLC-yl and Syp
To confirm that the binding sites for PLC-1yl lie within
the carboxy-terminal region of the [ PDGF receptor and
are lost by truncation, we immunoprecipitated PLC-yl
and performed a western blot using the 4G10 anti-phos-
photyrosine antibody. PDGF stimulation of untransfected
PC12 cells did not promote phosphorylation of PLC--yl
on tyrosine (Fig. 6a, lanes 1-2). Following PDGF stimula-
tion of Balb/c 3T3 cells (Fig. 6a, lanes 7-8) or PC12 cells
expressing the full-length (WT) PDGF receptor (Fig. 6a,
lanes 3-4; Fig. 6b, lanes 1-2), however, PLC-y/1 was phos-
phorylated on tyrosine and co-precipitated with tyrosine-
phosphorylated PDGF receptor. This association was dis-
rupted in PC12 cells expressing either the Trunc (Fig. 6a,
lanes 5-6) or the 4F PDGF receptor (Fig. 6B, lanes 3-4).
Syp also became phosphorylated and co-precipitated
with tyrosine-phosphorylated PDGF receptor following
PDGF stimulation of Balb/c 3T3 cells (Fig. 7a, lanes
8-9) and PC12 cells expressing the full-length WT
PDGF receptor (Fig. 7a, lanes 4-5). This association
between Syp and the PDGF receptor was not observed
in untransfected PC12 cells stimulated with either PDGF
or NGF (Fig. 7a, lanes 1-3). Syp was, however, also
phosphorylated on tyrosine in response to PDGF in cells
expressing either the Trunc (Fig. 7a, lanes 6-7) or the 4F
PDGF receptor (Fig. 7b, lanes 3-4). The expression of
the 4F PDGF receptor was lower than that of the WT
receptor, perhaps contributing to the weaker observed
Syp phosphorylation in response to PDGF in these cells.
When the western blot was stripped and re-probed with
an antibody specific for Syp, equal amounts of Syp were
detected in all PC12 lanes, and the tyrosine-phosphory-
lated forms of the Syp protein were shifted in mobility
(data not shown). Although the reported binding site for
Syp, the tyrosine at residue 977, had been eliminated in
Fig. 7. Syp association with the PDGF
receptor in PC12 cells is not disrupted by
deletion of the receptor's carboxy-termi-
nal tail. Syp was immunoprecipitated
from cell lysates and the immunopre-
cipitated proteins resolved on a 6 % SDS
polyacrylamide gel, transferred to nitro-
cellulose and probed with an anti-phos-
photyrosine antibody (4G10). (a) Un-
transfected PC12 cells (lanes 1 3), PC12
cells expressing WT (lanes 4-5) or Trunc
(lanes 6-7) PDGF receptor, or Balb/c 3T3
cells (lanes 8-9) were either left unstimu-
lated (-) or stimulated with 50 ng ml-'
NGF (N) or 40 ng ml 1 PDGF BB (P) for 5
minutes at 37 C before lysis. (b) PC12
cells expressing the 4F PDGF receptor
(lanes 3-4) were either left unstimulated
(-) or stimulated with 40 ng ml-1 PDGF
BB (P). Lanes of lysates from unstimulated
or PDGF-stimulated PC12 cells express-
ing the WT PDGF receptor (lanes 1-2) are
included for reference.
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both the Trunc and the 4F forms of the receptor, small
amounts of tyrosine-phosphorylated receptor were still
found to co-precipitate with Syp in each case (Fig. 7a,
lanes 6-7; Fig. 7b, lanes 3-4), with the Trunc receptor
migrating slightly faster than the full-length WT. These
results suggest that, in PC12 cells, Syp may interact with
alternative sites on the PDGF receptor when its primary
binding sites are eliminated.
All forms of the PDGF receptor activate MAP kinase in
PC12 cells stimulated with PDGF
MAP kinase activation is likely to be an important step
in the signal transduction cascade leading to NGF-
dependent differentiation of PC12 cells [27]. We wanted
to determine whether PC12 cells expressing any forms
of the PDGF receptor have lost the ability to activate the
pp42/pp44 MAP kinases following PDGF stimulation.
When an in-gel myelin basic protein (MBP) kinase assay
was performed, we observed that stimulation of untrans-
fected PC12 cells with NGF, but not with PDGF, caused
pp42/pp44 MAP kinase activation (Fig. 8a, lanes 1-3).
MAP kinase activation in response to PDGF was
observed in Balb/c 3T3 cells (Fig. 8a, lanes 10-11) and
in PC12 cells expressing the full-length (WT) PDGF
receptor (Fig. 8a, lanes 4-5, Fig. 8b, lanes 3-4). MAP
kinase activation was also apparent following PDGF
stimulation of PC12 cells expressing both the AKI
and the Trunc forms of the receptor (Fig. 8a, lanes
6-9). These results were confirmed by immune-com-
plex kinase assays using soluble MBP as a substrate
(M. McMahon, personal communication). In addition,
PC12 cells expressing the 4F PDGF receptor responded
to PDGF with activation of pp42/pp44 MAP kinases
(Fig. 8b, lanes 1-2).
All forms of the PDGF receptor promote neurite outgrowth
Untransfected PC12 cells differentiated and- extended
neurites following treatment with NGF, but responded to
neither PDGF BB nor PDGF AA (Fig. 9a-c; and data
not shown). PC12 cells expressing the full-length 
PDGF receptor (WT) responded to PDGF BB treatment
by initiating a differentiation response and elaborating
neurites (Fig. 9d-e) [13]. The neurite outgrowth
response was maximal 3 days after addition of PDGF, but
was not maintained, perhaps as a result of down-regula-
tion of the PDGF receptor. PC12 cells expressing the
AKI receptor extended neurites in response to PDGF
(Fig. 9f-g), as did cells expressing the Trunc receptor
(Fig. 9h-i) or the 4F receptor (Fig. 9j-k). But PC12 cells
expressing the 4F receptor showed a reduced fraction
of cells with neurites compared with the other clones.
All clones had detectable neurite outgrowth with
0.5-1 ng ml-' PDGF BB in the culture medium, with
maximal responses obtained at 2.5-5 ng ml-1 PDGF
(data not shown).
To determine whether the PDGF receptor might pro-
mote PC12 cell differentiation indirectly by activating
Trk, we tested the ability of PDGF to promote neurite
outgrowth in the presence of K252a. This alkaloid blocks
NGF-induced PC12 cell differentiation by inhibition of
Trk tyrosine kinase activity, but does not inhibit differen-
tiation in response to FGF [28-30]. Neurite extension in
response to PDGF was not blocked by K252a at concen-
trations that completely blocked Trk activation and
NGF-dependent differentiation (data not shown). In fact,
in the presence of K252a PDGF-dependent neurite out-
growth in PC12 cells was enhanced and stabilized, with
the neurites maintained for several weeks.
Many neurotrophic factors act not only as differentiation
factors but also as survival factors. In PC12 cells, NGF
not only promotes differentiation and neurite outgrowth
but also supports cell survival in serum-free medium
[31]. Although activation of the PDGF receptor was able
to promote neurite outgrowth and differentiation, PDGF
was not able to support PC12 cell survival in the absence
of serum (data not shown).
Another hallmark of NGF-regulated PC12 cell differ-
entiation is the enhanced expression pf the neuronal
growth-associated protein, GAP-43. We observed an
increase in GAP-43 expression in response to NGF but
not PDGF in PC12 cells expressing the the WT PDGF
receptor (data not shown). This suggests that the PDGF
receptor may act primarily to regulate neurite out-
growth and not other aspects of neuronal differentiation
in PC12 cells.
Fig. 8. PDGF receptor-mediated activa-
tion of pp42/pp44 MAP kinases in PC 12
cells does not depend upon sequences
in the kinase insert region or the car-
boxy-terminal tail. 50 jzg of protein from
each cell lysate was resolved on a 12 %
SDS polyacrylamide gel containing
0.5 mg ml-1 myelin basic protein, and
an in-gel myelin basic protein kinase
assay was performed. The gel was then
dried and exposed to Xomat AR film. (a)
Lysates were prepared from untrans-
fected PC12 cells (lanes 1-3); PC12
cells expressing WT (lanes 4-5), AKI(lanes 6-7) or Trunc (lanes 8-9) forms of the PDGF receptor; and from Balb/c 3T3 cells (lanes 10 11). (b) Lysates were prepared from
PC12 cells expressing the 4F PDGF receptor (lanes 1-2) or from Balb/c 3T3 cells (lanes 3-4), for reference. Before lysis, cells were
either left unstimulated (-) or stimulated with 50 ng ml 1 NGF (N) or 40 ng ml 1 PDGF BB (P) for 5 minutes at 37 °C.
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Discussion and conclusions
Receptor protein-tyrosine kinases become activated in
response to extracellular signals that regulate either cell
proliferation or the initiation and maintenance of a differ-
entiated phenotype. In both situations, similar intracellular
signalling pathways seem to be activated. This raises the
Fig. 9. PDGF promotes neurite outgrowth of PC12 cells express-
ing WT, AKI and Trunc forms of the PDGF receptor. PC12 cells
were plated onto collagen IV-coated plates and grown in the pres-
ence or absence of growth factor for 3 days. (a) Untreated cells.
(b) Cells treated with 50 ng ml-1 NGF. (c) Cells treated with
40 ng ml-' PDGF BB. (d) Untreated cells expressing the WT
PDGF receptor. (e) Cells expressing the WT PDGF receptor,
treated with 40 ng ml - ' PDGF BB. (f) Untreated cells expressing
the AKI PDGF receptor. (g) Cells expressing the AKI PDGF recep-
tor, treated with 40 ng ml-1 PDGF BB. (h) Untreated cells express-
ing the Trunc PDGF receptor. (i) Cells expressing the Trunc PDGF
receptor, treated with 40 ng ml -1 PDGF BB. (j) Untreated cells
expressing the 4F PDGF receptor. (k) Cells expressing the 4F
PDGF receptor, treated with 40 ng ml-' PDGF BB.
question of whether the signal transduction pathways
involved in regulating mitogenesis are also important in
controlling differentiation.
To investigate this issue, we have examined signalling by
the PDGF receptor in PC12 cells. PDGF promotes neu-
rite outgrowth when the PDGF receptor is expressed in
PC12 cells, indicating that intracellular signalling path-
ways regulating neurite extension are activated by the
PDGF receptor. PDGF-dependent neurites were main-
tained for less than a week, suggesting that the PDGF
receptor might become down-regulated with prolonged
exposure to PDGE
The PDGF receptor in PC12 cells may activate a subset
of the complete signalling cascade that is activated by
endogenously expressed receptor tyrosine kinases, such as
Trk and the FGF receptor, as the PDGF receptor pro-
moted neurite outgrowth but did not promote PC12 cell
survival in serum-free medium, nor did it induce GAP-
43 expression. This would suggest that neurite out-
growth and these other manifestations of differentiation
are functionally separable. Precedent exists for such func-
tional segregation, as isoforms of the TrkC receptor pro-
mote neurite outgrowth but not survival in serum-free
medium when expressed in PC12 cells [32].
The PDGF receptor promotes neurite outgrowth without
signalling through P 3-kinase, Ras-GAP or PLC-yl
The neurite outgrowth response to PDGF did not
depend upon sequences in the kinase insert region or the
carboxy-terminal tail of the PDGF receptor, suggesting
that association with the PDGF receptor of Ras-GAP, PI
3-kinase, or PLC-'yl is not required for this differentia-
tion response in PC12 cells. Association of Nck with the
receptor may also be dispensable for neurite outgrowth,
as Nck appears to share a binding site with PI 3-kinase
[19]. It has recently been shown that the association of PI
3-kinase with Trk is not required for NGF-regulated
PC12 cell differentiation, consistent with our observa-
tions using the PDGF receptor [12]. In addition, elimi-
nation of the PLC-y1 binding site on Trk does not
abolish neurite outgrowth in response to NGF, but does
abrogate peripherin induction [33].
The fraction of cells bearing neurites following PDGF
treatment was less for the cell lines expressing the 4F
PDGF receptor than for the other PDGF receptor-
expressing clones. The 4F receptor was expressed at
lower levels than the other forms, perhaps accounting for
the reduced fraction of cells bearing neurites. It is also
possible that the effect of disrupting signalling through
PLC-yl and PI 3-kinase in combination results in a
reduced ability of these cells to extend neurites in
response to PDGE
We observed that association of both the Trunc and 4F
forms of the PDGF receptor with the protein tyrosine
phosphatase, Syp, was reduced but not eliminated, even
though the reported binding site for Syp, tyrosine 977,
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had been removed in these two receptor forms. It is pos-
sible that Syp binds to an alternative site in the PDGF
receptor when its primary binding site is removed.
Individual SH2 domains, such as that used by Syp to bind
to the PDGF receptor, bind with high affinity to phos-
photyrosine residues in the context of a specific peptide
sequence, but may also interact with other phosphotyro-
sine-containing sequences with lower affinity [34]. Other
mutants of the PDGF receptor may also retain some resid-
ual binding to associated proteins whose primary binding
sites have been removed. Although not detectable in our
assays, such residual associations might contribute func-
tionally to signalling by the receptor. PC12 cells, in par-
ticular, may be more responsive to signalling by such
residual associated proteins than other cell types.
MAP kinase activation by the PDGF receptor
We observed that the pp42/pp44 MAP kinases were
activated in PC12 cells expressing the WT, AKI and
Trunc forms of the PDGF receptor. In each case, there-
fore, some elements of the signal transduction cascade
leading to activation of the MAP kinases must be intact.
MAP kinase activation is central to the regulation of
PC12 cell differentiation by NGF If MAP kinase activa-
tion is blocked using interfering mutants of MAP kinase
kinase, PC12 cells no longer extend neurites in response
to NGF [35]. In addition, constitutively active forms of
MAP kinase kinase activate MAP kinase and lead to
neurite outgrowth when expressed in PC12 cells [35].
Additional isoforms of MAP kinase may also participate
in signal transduction from the PDGF receptor but
were not examined here. The activation of MAP kinases
in response to NGF stimulation of PC12 cells is
Ras-dependent, as dominant-negative alleles of ras
block both PC12 cell differentiation and MAP kinase
activation [36,37].
Receptor tyrosine kinases probably regulate MAP kinase
activity in several ways. One pathway begins with Grb2,
the SH2/SH3-domain-containing protein that is consti-
tutively bound to the guanine nucleotide exchange factor
mSOS [38-45]. When Grb2 associates with activated
receptor tyrosine kinases, mSOS is brought into proxim-
ity with the plasma membrane, where it can regulate the
amount of GTP-bound Ras. GTP-bound Ras forms a
complex with Raf-1 [46-51], which becomes activated
and phosphorylates MAP kinase kinase [52-54]. This
kinase then phosphorylates and activates the MAP kinases
(reviewed in [55]). In the case of the PDGF receptor,
Grb2 has been shown to complex with the receptor)in-
directly, by binding to phosphotyrosine residues on the
receptor-associated protein Syp [56]. As the Trunc PDGF
receptor associated with Syp despite lacking the reported
binding site for Syp, none of the PDGF receptor mutants
that we expressed in PC12 cells completely disrupts this
arm of the Ras activation pathway.
Receptor tyrosine kinases may also couple to Ras by
other means. For example, the PDGF receptor associates
with and activates the Src family tyrosine kinases, Src, Yes
and Fyn [57]. Shc is phosphorylated on tyrosine in v-src-
transformed cells and is potentially a direct substrate for
the Src tyrosine kinase [58]. In addition, it has recently
been shown that Shc interacts directly with the PDGF
receptor [59]. As a result, following PDGF stimulation of
cells, Shc becomes phosphorylated on tyrosine and asso-
ciates with Grb2 [60,61], thus linking with the pathway
described above. Alternatively, Ras may be activated as a
consequence of protein kinase C activation, such as
occurs following an increase in PI turnover [62,63]. In
addition, there may be ways of regulating MAP kinase
activity that are independent of Ras or independent of
Raf-1, for example through MEKK [64], although it is
not clear how these pathways might couple to receptor
kinase activation.
The PDGF receptor elements required for neurite outgrowth
are distinct from those required for mitogenesis
In PC12 cells, Ras-GAP, PI 3-kinase, and PLC-yl are
not essential for PDGF-regulated neurite outgrowth. But
the binding sites on the PDGF receptor for some of these
signalling molecules are important for PDGF-mediated
mitogenesis. Ras-GAP enhances the intrinsic GTPase
activity of Ras and has been proposed to act as either a
negative regulator of Ras or, in some cases, as an effector
of Ras (reviewed in [65]). The phosphorylation of
Ras-GAP on tyrosine and binding to the PDGF receptor
is not important for PDGF-stimulated cell proliferation
in epithelial and fibroblast cell lines, however [16-18]. In
addition, association with Ras-GAP is not required for
Ras activation following stimulation of either Chinese
hamster ovary (CHO) cells or pro-B-cell BaF3 cells
expressing the PDGF receptor [66]. Likewise, we have
found that in PC12 cells, association of Ras-GAP with
the PDGF receptor is not required for either differentia-
tion or MAP kinase activation. In general, it is not clear
what role Ras-GAP may play in mediating the biological
effects of PDGF, as it has been shown that the PDGF
receptor regulates Ras activity largely by modulating
guanine nucleotide exchange activity [67]. As activation
of Trk - the receptor for NGF - does not lead to
phosphorylation of Ras-GAP or its association with Trk,
it is perhaps not surprising that Ras-GAP does not seem
to play a role in regulating PC12 cell differentiation.
In some cell types, the PI 3-kinase/Nck binding sites on
the PDGF receptor must be intact for PDGF to be able
to promote DNA synthesis. When these residues are
deleted or mutated and the PDGF receptor is expressed
in epithelial cells, for example, PDGF no longer activates
PI 3-kinase, no longer elicits an increase in the amount
of GTP-bound Ras, does not stimulate the activities of
Raf-1 and MAP kinases, and does not promote DNA
synthesis [16,17,66]. Recently it has been shown that PI
3-kinase interacts physically with the GTP-bound form
of Ras and is likely to serve as an effector for Ras [68].
Association of PI 3-kinase with the PDGF receptor is
also required for normal endocytic trafficking of the
receptor, although how this influences signalling by the
receptor is not known [69].
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In contrast, we have shown that in PC12 cells, the PI 3-
kinase binding sites on the PDGF receptor are not
required for neurite outgrowth nor for pp42/pp44 MAP
kinase activation. In this respect, the requirements for
PDGF-mediated mitogenesis are distinct from those for
PDGF-dependent neurite outgrowth. In addition, there
may be some cell-type specificity with respect to how
the same receptor communicates with downstream sig-
nalling pathways. For example, in contrast to the situa-
tion in epithelial cells, when the PDGF receptor is
expressed in the pro-B-cell line BaF3, the integrity of
the PI 3-kinase binding sites on the PDGF receptor is
not important for the observed increase in the amount of
GTP-bound Ras [66].
When the phosphotyrosine residues mediating the associ-
ation of PLC-yl1 with the PDGF receptor are mutated,
there is a reduction in the amount of DNA synthesis
detected following PDGF stimulation in some [23], but
not all [24] cell types. In PC12 cells, association of PLC-
'yl with the PDGF receptor is not essential for the ability
of the receptor to promote MAP kinase activation and
neurite outgrowth, providing another example of a case
in which the requirements for PDGF-stimulated mito-
genesis and differentiation are distinct.
Our findings with PC12 cells suggest that the importance
of individual signalling pathways may vary depending on
the cell type in which the PDGF receptor is expressed,
or on the ultimate phenotypic outcome of signalling. In
addition, the PDGF receptor may use multiple redundant
pathways to exert a biological effect, and there may be
compensation between these pathways when any one
pathway is compromised. PC12 cell neurite outgrowth
may depend upon the activation of known signal trans-
duction components, such as the MAP kinases, or may
require the activity of other signalling molecules. These
might include either identified signalling molecules, such
as the Stat proteins [70-72], or novel proteins in growth
factor receptor signal transduction. At this time, the
identity of the critical signal transduction pathway(s)
mediating PDGF-dependent neurite outgrowth in PC12
cells is unknown.
Materials and methods
Materials
Polyclonal antibodies specific for the platelet-derived growth
factor receptor subunit were obtained from L.T. Williams
(Ab65) or from Upstate Biotechnology Inc. (catalog #06-131).
The following antisera were also obtained from Upstate
Biotechnology Inc.: polyclonal antisera specific for Ras GAP
(catalog #06-153), mixed monoclonal antibodies recognizing
PLC-'yl (catalog #05-163), and polyclonal antisera specific for
Syp (catalog #06-118). A monoclonal antibody recognizing
Syp was obtained from Transduction Laboratories (catalog
#P17420). The anti-phosphotyrosine monoclonal antibody
4G10 was provided by D. Morrison, B. Drucker and T.
Roberts. Nerve growth factor (Boehringer Mannheim) was
used at a concentration of 50 ng ml-' and human recombinant
platelet derived growth factor BB (Upstate Biotechnology Inc.)
at a concentration of 40 ng ml- '.
Cell culture and neurite outgrowth assays
PC12 cells were maintained in Dulbecco's Modified Eagle's
medium (DMEM) supplemented with 5% horse serum derived
from platelet-poor plasma (Sigma). For analysis of neurite out-
growth, cells were seeded into 24-well collagen IV biocoat
plates (Collaborative Biomedical Products), and cultured in the
presence of NGF or PDGF BB for several days.
PDGF receptor cDNA constructs and expression
All mouse PDGF receptor cDNAs (wild-type and mutant)
were a generous gift from J. Escobedo and L.T. Williams. The
AKI, Trunc and the 4F forms of the PDGF receptor are
described in the Results section and in Fig. 1. The cDNAs
encoding all forms of the receptor were cloned into the CMV
expression vector pCEN (a generous gift from J. Majors).
Plasmid was introduced into PC12 cells by electroporation and
the cells selected in G418 (300 plg ml-1). G418-resistant clones
were screened for PDGF receptor expression by western blot
analysis of cell lysates using an antibody specific for the 13
PDGF receptor (Ab 65; a gift from L.T. Williams). Two inde-
pendent cell lines expressing each P)GF receptor construct
were used in all experiments. In each case, all results were
identical for both cell lines.
Preparation of cell extracts, immunoprecipitation and
immunoblotting
For preparation of cell extracts, PC12 cells (1 x 107) or conflu-
ent Balb/c 3T3 cells (3 x 106) were stimulated with growth
factor and the cells were lysed as described previously [10] in
1 % Nonidet P-40 lysis buffer (50 mM Hepes buffer, pH 7.4,
150 mM NaCI, 10 % glycerol, 1.5 mM MgC1, 1 mM EGTA,
100 mM NaF, 1 % Nonidet P-40, 1 mM Pefabloc, 10 lag ml 1
aprotinin, 10 lg mnl- leupeptin, 1 mM sodium orthovana-
date). Immunoprecipitations were carried out and resolved by
SDS polyacrylamide gel electrophoresis (SDS-PAGE) as
described [10]. Western immunoblots were performed using
the Enhanced Chemiluminescence (ECL) detection system
(Amersham).
In-gel myelin basic protein kinase and PI 3-kinase assays
For the in-gel myelin basic protein kinase assay, 50-100 (lg
total cell protein was electrophoresed through a 12.5 % SDS
polyacrylamide gel containing 500 lpg nil- myelin basic pro-
tein, and the assay was carried out as described previously [73].
For the PI 3-kinase assay, the PIDGF receptor was immuno-
precipitated from PC12 or Balb/c 3T3 cell lysates and the PI
3-kinase assay carried out as described previously [16].
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